Product Information

AMLODIPINE-BENAZEPRIL 10-40 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1536 per EA under NDC 68180047301. Its NADAC has been published 377 times since Jun 5, 2019.

FDA first approved this application on Feb 5, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-BENAZEPRIL 10-40 MG

Amlodipine Besylate and Benazepril Hydrochloride
$0.1536per EA

Strength

10; 40 mg/1; mg/1

NDC

68180047301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078466

FDA Approved

2/5/2010

TE Code

AB

On Market Since

10/4/2018

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has been published 377 times since Jun 5, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1536 per EA
All-time high$0.1939 (Oct 13, 2021)
All-time low$0.1070 (Jul 17, 2024)
52-week high$0.1578
52-week low$0.1484
Median price$0.1597
Average price$0.1580
Largest weekly change+41.2% (Aug 21, 2024)
Weeks tracked377
Tracking sinceJun 5, 2019

Price History

1W

+1.9%

1M

+1.9%

3M

+1.3%

6M

-2.3%

1Y

+2.0%

3Y

-6.1%

5Y

-17.8%

All

+0.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-BENAZEPRIL 10-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 10-40 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.1536 per EA (NDC 68180047301), effective Aug 19, 2026.

How has the price of AMLODIPINE-BENAZEPRIL 10-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has held within roughly two percent of its current level. It has been tracked across 377 weekly CMS publications since Jun 5, 2019.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 10-40 MG?

Since Jun 5, 2019, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has ranged from a low of $0.1070 (Jul 17, 2024) to a high of $0.1939 (Oct 13, 2021), with a median of $0.1597 per EA.

Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 10-40 MG?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 10-40 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-BENAZEPRIL 10-40 MG?

AMLODIPINE-BENAZEPRIL 10-40 MG (NDC 68180047301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.